44
Views
5
CrossRef citations to date
0
Altmetric
ARTICLES

Fibromyalgia and Related Medically Unexplained Symptoms: A Lost Link Between Cardiovascular and Nociception Modulation

, PhD & , MD
Pages 67-79 | Received 23 Aug 2006, Accepted 28 Mar 2007, Published online: 10 Jul 2009

REFERENCES

  • Nampiaparampil D E, Shmerling R H. A review of fibromyalgia. Am J Manag Care 2004; 10: 794–800
  • Bernatsky S, Dobkin B L, De Civita M, Penrod J R. Comorbidity and physician use in fibromyalgia. Swiss Med Wkly 2005; 135: 76–81
  • Picavet H SJ, Hoeymans N. Health-related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC-3 study. Ann Rheum Dis 2004; 63: 723–729
  • Russell I J. Fibromyalgia syndrome. Bonica's Management of Pain, 3rd Ed, J D Loeser, S H Butler, C R Chapman, D C Turk. Lippincott Williams & Wilkins Publishers, Philadelphia, PA 2001
  • Buckhardt C S, Goldenberg D, Crofford L, Gerwin R, Gowens S, Jackson K, et al. Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children. American Pain Society, Glenview, IL 2005; 109
  • Goldenberg D L, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292: 2388–2395
  • Ciccone D S, Natelson B H. Comorbid illness in women with chronic fatigue syndrome: A test of the single syndrome hypothesis. Psychosom Med 2003; 65: 268–275
  • Maiden N L, Hurst N P, Lochhead A, Carson A J, Sharpe M. Medically unexplained symptoms in patients referred to a specialist rheumatology service: Prevalence and associations. Rheumatology 2003; 42: 108–112
  • Reeves W C, Lloyd A, Vernon S D, Klimas N, Jason L A, Bleijenberg G, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003; 3: 25
  • Fukuda K, Straus S E, Hickie I, Sharpe M C, Dobbins J G, Komaroff A. The chronic fatigue syndrome a comprehensive aproach to its definition and study. Ann Intern Med 1994; 121(12)953–959
  • Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160–172
  • Laske C, Stransky E, Eschweiler G W, Klein R, Wittorf A, Leyhe T, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatric Res, (in press)
  • Sarchielli P, Alberti A, Candeliere A, Floridi A, Capocchi G, Calabresi P. Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia 2006; 26: 409–415
  • Denko C W, Malemud C J. Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 2005; 25: 146–151
  • Baraniuk J N, Whalen G, Cunningham J, Clauw D J. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskeletal Disord 2004; 5: 48
  • McCall-Hosenfeld J S, Goldenberg D L, Hurwitz S, Adler G K. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 2003; 30(4)809–814
  • Gursoy S, Erdal E, Herken H, Madenci E, Alaaehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003; 23: 104–107
  • Cleare A J, Miell J, Heap E, Sookdeo E, Young L, Malhi G S, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001; 86: 3545–3554
  • Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B. Association of T102C polymorphism of the5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 2001; 21: 58–61
  • Wallace D J, Linker-Isralei M, Hallegua D, Silverman S, Silver D, Weisman M H. Cytokines play an aetiopathogenic role in fibromyalgia: A hypothesis and pilot study. Rheumatology 2001; 40: 743–749
  • Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotoninergic system in fibromyalgia patients. Scand J Rheumatol 2000; 113: 8–12
  • Larson A A, Giovengo S L, Russel I J, Michalek J E. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: Implication for nitric oxide pathways. Pain 2000; 87: 201–211
  • Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42: 2482–2488
  • Adler G K, Kinsley B T, Hurwitz S, Mossey C J, Goldenberg D L. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106: 534–543
  • Klein R, Berg P A. High incidence of antibodies to 5-hydroxytryptamine gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: Evidence for a clinical entity of both disorders. Eur J Med Res 1995; 1: 21–26
  • Russell I J, Orr M D, Littman B, Vipraio G A, Alboukrek D, Michalek J E, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593–1601
  • McBeth J, Chiu Y H, Silman A J, Ray D, Morris R, Dickens C, et al. Hypothalamic-pituitary-adrenal stress axis function and the relantionship with chronic widespread pain and its antecedents. Arthritis Res Ther 2005; 7: R992–R1000
  • Gur A, Cevik R, Sarac A J, Colpan L, Em S. Hypothalamic-pituitary-gonadal axis and cortisol in young women with fibromyalgia: The potential roles of depression fatigue and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis 2004; 63: 1504–1506
  • Crofford L J, Pillemer S R, Kalogeras K T, Cash J M, Michelson D, Kling M A, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–1592
  • Ehrlich G E. Pain is real; fibromyalgia isn't. J Rheumatol 2003; 30: 1666–1667
  • Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 2003; 30: 1671–1672
  • Hadler M N. “Fibromyalgia” and the medicalization of misery. J Rheumatol 2003; 30: 1668–1670
  • Gordon D A. Fibromyalgia. Real or imagined?. J Rheumatol 2003; 30: 1665
  • Werle E, Fischer H P, Muller A, Fiehn W, Eich W. Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rheumatol 2001; 28: 595–600
  • Barsky A J, Borus J F. Functional somatic syndromes. Ann Intern Med 1999; 130: 910–921
  • Hudson J I, Arnold L M, Keck P E, Auchenback M B, Pope H G. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004; 56: 884–891
  • Sayar K, Gulec H, Topbas M, Kalyoncu A. Affective distress and fibromyalgia. Swiss Med Wkly 2004; 134: 248–253
  • Henningsen P, Zimmerman T, Sattel H. Medically unexplained physical symptoms anxiety and depression: A meta-analytic review. Psychosom Med 2003; 65: 528–533
  • Procee H. Semiotics and fibromyalgia. Rheumatology 2004; 43: 255–257
  • Hazemeijer I, Rasker J J. Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting. Rheumatology 2003; 42: 507–515
  • Ulas U H, Unlu E, Hamamcioglu K, Odabasi Z, Cakci A, Vural O. Dysautonomia in fibromyalgia syndrome: Sympathetic skin responses and RR interval analysis. Rheumatol Int 2006; 26(5)383–387
  • Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F, et al. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 2005; 32: 1787–1793
  • Goldstein D S, Robertson D, Esler M, Straus S E, Eisenhofer G. Dysautonomias: Clinical disorders of the autonomic nervous system. Ann Intern Med 2002; 137: 753–763
  • Martínez-Lavín M. Management of dysautonomia in fibromyalgia. Rheum Dis Clin N Am 2002; 28: 379–387
  • Cohen H, Neumann L, Kotler M, Buskila D. Autonomic nervous system derangement in fibromyalgia syndrome and related disorders. IMAJ 2001; 3: 755–760
  • Raj S R, Brouillard D, Simpson C S, Hopman W M, Abdollah H. Dysautonomia among patients with fibromyalgia: A noninvasive assesment. J Rheumatol 2000; 27: 2660–2665
  • Martínez-Lavín M, Hermosillo A G, Mendoza C, Ortiz R, Cajigas J C, Pineda C, et al. Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 1997; 24: 714–718
  • Martínez-Lavín M, Hermosillo A G, Rosas M, Soto M. Circadian studies of autonomic nervous balance in patients with fibromyalgia. Arthritis Rheum 1998; 41(11)1966–1971
  • Bou-Holaigah I, Rowe P C, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274: 961–967
  • Rowe P C, Bou-Holaigah I, Kan J S, Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?. Lancet 1995; 345: 623–624
  • Bou-Holaigah I, Calkins H, Flynn J A, Tunin C, Chang H-C, Kan J S, et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997; 15: 239–246
  • Furlan R, Colombo S. Síndrome fibromialgica e sistema nervoso autonomo. Progressi in Reumatologia 2001; 1: 47–53
  • Naschitz J E, Rosner I, Rozenbaum M, Naschitz S, Musafia-Priselac R, Shaviv N, et al. The head-up tilt test with haemodynamic instability score in diagnosing chronic fatigue syndrome. Q J Med 2003; 96: 133–142
  • Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, et al. Chronic orthostatic intolerance. A disorder with discordant cardiac and vascular sympathetic control. Circulation 1998; 98: 2154–2159
  • Schondorf R, Low P A. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?. Neurology 1993; 43(1)132–137
  • Stewart J M, Weldon A. Vascular perturbations in the chronic orthostatic intolerance of the postural orthostatic tachycardia syndrome. J Appl Physiol 2000; 89: 1505–1512
  • Novak V, Novak P, Opfer-Gehrking T L, Low P A. Postural tachycardia syndrome: Time frequency mapping. J Auton Nerv Syst 1996; 61(3)313–320
  • Low P A, Opfer-Gehrking T L, Textor S C, Schondorf R, Suarez G A, Fealey R D, et al. Comparison of the postural tachycardia syndrome (POTS) with osthostatic hypotension due to autonomic failure. J Auton Nerv Syst 1994; 50(2)181–188
  • Stewart J M. Microvascular filtration is increased in postural tachycardia syndrome. Circulation 2003; 107: 2816–2822
  • Stewart J M. Pooling in chronic orthostatic intolerance. Arterial vasoconstrictive but not venous compliance defects. Circulation 2002; 105: 2274–2281
  • Stewart J M, Weldon A. Reflex vascular defects in the orthostatic tachycardia syndrome in adolescents. J Appl Physiol 2001a; 90: 2025–2032
  • Stewart J M, Weldon A. The relation between lower limb pooling and blood flow during orthostasis in the postural orthostatic tachycardia syndrome of adolescents. J Pediatr 2001b; 138: 512–519
  • Schondorf R, Benoit J, Stein R. Cerebral autoregulation is preserved in postural tachycardia syndrome. J Appl Physiol 2005; 99(3)828–835
  • Jáuregui-Renaud K, Hermosillo J AG, Jardón J L, Márquez M F, Kostine A, Silva M A, et al. Cerebral blood flow during supine rest and the first minute of head-up tilt in patients with orthostatic intolerance. Europace 2005; 7: 460–464
  • Hermosillo J AG, Jáuregui-Renaud K, Kostine A, Márquez M F, Lara J L, Cárdenas M. Comparative study of cerebral blood flow between postural tachycardia and neurocardiogenic syncope during head-up tilt test. Europace 2002; 4: 369–374
  • Jacob G, Atkinson D, Jordan J, Shannon J R, Furlan R, Black B K, et al. Effects of standing on cerebrovascular resistance in patients with idiopathic orthostatic intolerance. Am J Med 1999; 106(1)59–64
  • Jordan J, Shannon J R, Black B K, Paranjape S Y, Barwise J, Robertson D. Raised cerebrovascular resistance in idiopathic orthostatic intolerance. Evidence for sympathetic vasoconstriction. Hypertension 1998; 32: 699–704
  • Backman E, Bengtsson A, Bengtsson M, Lennmarken C, Henriksson K G. Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine. Acta Neurol Scand 1988; 77: 187–191
  • Vaeroy H, Qiao Z G, Morkrid L, Forre O. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989; 16: 1460–1465
  • Stewart J M, Gewitz M H, Weldon A, Arlievsky N, Li K, Munoz J L. The nature of orthostatic intolerance in adolescents with the chronic fatigue syndrome. Pediatrics 1999; 103: 116–121
  • Stewart J M, Weldon A A, Munoz J L. Pattern of orthostatic intolerance: The orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999; 135: 218–225
  • Farquhar W B, Taylor A, Darling S E, Chase K P, Freeman R. Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation 2000; 102: 3086–3091
  • Jacob G, Costa F, Shannon J R, Robertson R M, Wathen M, Stein M, et al. The neuropathic postural tachycardia syndrome. N Engl J Med 2000; 343: 1008–1014
  • Jacob G, Robertson D, Mosqueda-Garcia R, Ertl A C, Robertson R M, Biaggioni I. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 1997; 103: 128–133
  • Robertson D, Hollister A S, Biaggioni I, Netterville J L, Mosqueda-Garcia R, Robertson R M. The diagnosis and treatment of baroreflex failure. N Engl J Med 1993; 329: 1449–1455
  • Garland E M, Winker E M, Williams S M, Jiang L, Stanton K, Byrne D W, et al. Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension 2005; 46: 1103–1110
  • Clifford P S, Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol 2004; 97: 393–403
  • Winker R, Garland E, Rudiger H, Diedrich A, Biaggioni I, Ponocny I, et al. Influence of an insertion variant in the 5′ UTR of the endothelin gene on orthostatic intolerance. Am J Med Sci 2005a; 330(4)166–171
  • Popowski K, Sperker B, Kroemer H K, John U, Laule M, Stangl K, et al. Functional significance of a hereditary adenine insertion variant in the 5′-UTR of the endothelin-1 gene. Pharmacogenetics 2003; 13(8)445–451
  • Jacob G, Garland E M, Costa F, Stein C M, Xie H-G, Robertson R M, et al. β -2 adrenoceptor genotype and function affect hemodynamic profile heterogeneity in postural tachycardia syndrome. Hypertension 2006; 47: 421
  • Winker R, Barth A, Valic E, Maier R, Osterode W, Pilger A, et al. Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. Int Arch Occup Environ Health 2005b; 78(3)171–177
  • Tabara Y, Kohara K, Miki T. Polymorphisms of genes encoding components of the sympathetic nervous system but not the renin-angiotensin system as risk factors for orthostatic hypotension. J Hypertens 2002; 20(4)651–656
  • Behnke B J, Padilla D J, Ferreira L F, Delp M D, Musch T I, Poole D C. Effects of arterial hypotension on microvascular oxygen exchange in contracting skeletal muscle. J Appl Physiol 2006; 100: 1019–1026
  • Stewart J M, Medow M S, Montgomery L D, McLeod K. Decreased skeletal muscle pump in patients with postural tachycardia syndrome and low peripheral blood flow. Am J Physiol Heart Circ Physiol 2004; 286: 1216–1222
  • Staud R, Vierck C J, Robinson M E, Price D D. Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 2004; 111: 342–350
  • Staud R, Robinson M E, Vierck C J, Jr, Cannon R L, Mauderli A P, Price D D. Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 2003; 105: 215–222
  • Staud R, Vierck C J, Cannon R L, Mauderli A P, Price D D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91: 165–171
  • Brain S D, Grant A D. Vascular actions of calcitonin-related peptide and adrenomedullin. Physiol Rev 2004; 84: 903–934
  • Hinson J P, Kapas S, Smith D M. Adrenomedullin a multifunctional regulatory peptide. Endocr Rev 2000; 21(2)138–167
  • Subhash M N, Nagaraja M R, Sharada S, Vinod K Y. Cortinal alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 2003; 43: 603–609
  • Tolk J, Kohnen R, Muller W. Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice. Scand J Rheumatol 2004; 119: 72–75
  • Farber L, Stratz T H, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized double-blind placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res 2001; 21(1)1–13
  • Papadopoulos I A, Georgiou P E, Katsimbri P P, Drosos A A. Treatment of fibromyalgia with tropisetron a 5HT3 serotonin antagonist: A pilot study. Clin Rheumatol 2000; 19(1)6–8
  • Jasmin L, Tien D, Weinshenker D, Palmiter R D, Green P G, Janni G, et al. The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc Natl Acad Sci USA 2002; 99: 1029–1034
  • Sagen J, Proudfit H K. Effect of intrathecally administered noradrenergic antagonists on nociception in the rat. Brain Res 1984; 310: 295–301
  • Siddall P J, Molloy A R, Walker S, Mather L E, Rutkowski S B, Cousins M J. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg 2000; 91: 1493–1498
  • Mendez R, Eisenach J C, Kashtan K. Epidural clonidine analgesia after cesarean section. Anesthesiology 1990; 73: 848–852
  • Maes M, Libbrecht I, Delmeire L, Lin A, De Clerk L, Scharpe S, et al. Changes in platelet alpha-2-adrenoceptors in fibromyalgia: Effects of treatment with antidepressants. Neuropsychobiology 1999; 40(3)129–133
  • Campbell T S, Ditto B, Séguin J R, Sinray S, Tremblay R E. Adolescent pain sensitivity is associated with cardiac autonomic function and blood pressure over 8 years. Hypertension 2003; 41: 1228–1233
  • Ghione S. Hypertension-induced hypalgesia. Evidence in experimental animals and humans pathophysiological mechanisms and potential clinical consequences. Hypertension 1996; 28: 494–504
  • Dworkin B, Filewich R, Miller N, Craigmyle N, Pickering T. Baroreceptor activation reduces reactivity to noxious stimulation: Implications in hypertension. Science 1979; 205: 1299–1301
  • Thurston C L, Randich A. Effects of vagal afferent stimulation on ON and OFF cells in the rostroventral medulla: Relationships to nociception and arterial blood pressure. J Neurophysiol 1992; 67(1)180–196
  • Randich A, Ren K, Gebhart G F. Electrical stimulation of cervical vagal afferent II. Central relays for behavioral antinociception and arterial blood pressures decreases. J Neurophysiol 1990; 64(4)1115–1124
  • Hagen K, Zwart J A, Holmen J, Svebak S, Bovim G, Stovner L J. Does hypertension protect against chronic musculoskeletal complaints?. Arch Int Med 2005; 165(8)916–922
  • Shimoda O, Ikuta Y. The current perception thresholds vary between horizontal and 70ˆ tilt-up positions. Anest Analg 2000; 91: 398–402
  • Guasti L, Grimoldi P, Diolisi A, Petrozzino M R, Gaudio G, Grandi A M, et al. Treatment with enalapril modifies the pain perception pattern in hypertensive patients. Hypertension 1998; 31: 1146–1150
  • Jeschonneck M, Grohmann G, Hein G, Sprott H. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 2001; 39: 917–921
  • Koltyn K F, Umeda M. Exercise hypoalgesia and blood pressure. Sports Med 2006; 36(3)207–214
  • Pyke K E, Tschakovsky M E. The relationship between shear stress and flow-mediated dilation: Implications for the assessment of endothelial function. J Physiol 2005; 568: 357–369
  • Faulx M D, Wright A T, Hoit B D. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 2003; 145: 943–951
  • Lange F P, Kalkman J S, Bleijenberg G, Hagoort P, van der Werf S P, van der Meer J WM, et al. Neural correlates of the chronic fatigue syndrome—an fMRI study. Brain 2004; 127(9)1948–1957
  • Schmaling K B, Lewis D H, Fiedelak J I, Mahurin R, Buchwald D S. Single-photon emission computerized tomography and neurocognitive function in patients withchronic fatigue syndrome. Psychosom Med 2003; 65: 129–136
  • Lewis D H, Mayberg H S, Fischer M E, Goldberg J, Ashton S, Graham M M, et al. Monozygotic twins discordant for chronic fatigue syndrome: Regional cerebral blood flow SPECT. Radiology 2001; 219: 766–773
  • Schwartz R B, Garada B M, Komaroff A L, Tice H M, Gleit M, Jolesz F A, et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR Imaging and SPECT. Am J Roentgen 1994; 162: 935–941
  • Razumovsky A Y, DeBusk K, Calkins H, Snader S, Lucas K E, Vyas P, et al. Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome. J Neuroimaging 2003; 13: 57–67
  • Tanaka H, Matsushima R, Tamai H, Kajimoto Y. Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr 2002; 140(4)412–417

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.